Analytical Methods to Measure Subvisible Particulates

Analysis of Aggregates and Particles in Protein Pharmaceuticals

Volumn , Issue , 2012, Pages 85-115

  Cao, Shawn ^a   Narhi, Linda ^a   Jiang, Yijia ^a   Rajan, Rahul S ^a  

^a AMGEN INC   (United States)

Author keywords

Analytical challenges, in particle characterization, and USP<788>; Other techniques in subvisible, measurements, particulation mechanism crucial; Subvisible particulates, characterization techniques, and light obscuration

Indexed keywords

EID: 84886137952     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118150573.ch5     Document Type: Chapter

References (19)

1. Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. Protein Sci 2003;12:903-913.
2. Murphy R, Amos T, editors. Misbehaving proteins: protein (mis) folding, aggregation, and stability. Springer-Verlag New York, Inc; 2006.
3. Mahler H-C, Friese W, Grauschopf U, Kriese S. Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 2009;98:2909-2934.
4. Weiss WF, Young TM, Roberts CJ. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci 2009;98:1246-1277.
5. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 2004;15:3-16.
6. Tyagi AK, Randolph TW, Dong A, Maloney KM, Hitscherich C, Carpenter JF. IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. J Pharm Sci 2009;98:94-104.
7. Narhi LO, Cao S, Jiang Y, Benedek K, Shnek D. A critical review of analytical methods for subvisible and visible particles. Curr Pharm Biotechnol 2009;10:373-381.
8. Knapp JZ. Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems. PDA J Pharm Sci Technol 2003;54:218-232.
9. USP General Chapters: <788> Particulate matter in injections. Pharmacopeial Forum 2009;28:1930, USP32-NF27.
10. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G, Fan Y-X, Kirshner S, Verthelyi D, Kozklowski S, Crouse KA, Swann PG, Rosenberg A, Cherney B. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci 2009;98:1201-1205.
11. Cao S, Jiang Y, Narhi L. A light-obscuration method specific for quantifying subvisible particles in protein therapeutics. USP Pharmacopeial Forum 2010;36(3):824-834.
12. Coulter, WH. US patent 2,656,508. 1953.
13. Grover NB, Naaman J, Ben-Sasson S, Doljansk F. Electrical sizing of particles in suspensions. I. Theory. Biophys J 1969;9:1398-1413.
14. Harfield JG, Knight P. Experimental evidence of the linear response of the Coulter counter. In: Stanley-Wood NG, Allen T, editors. Particle size analysis 1981. Chichester: Wiley Heyden; 1982. pp. 199-208.
15. Sharma D, King D, Moore P, Oma P, Thomas D. Flow microscopy for particulate analysis in parenteral and pharmaceutical fluids. Eur J Parenter Pharm Sci 2007;12:97-101.
16. Chou DK, Krishnamurthy R, Randolph TW, Carpenter JF, Manning MC. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. J Pharm Sci 2005;94:1368-1381.
17. Randolph TW, Jones LS. Surfactant-protein interactions. Rational design of stable protein formulations. In: Carpenter JF, Manning MC, editors. Volume 13, Pharmaceutical biotechnology New York: Kluwer Academic/Plenum Publishers, New York; 2002. pp. 159-175.
18. Bam NB, Cleland JL, Yang J, Manning MC, Carpenter JF, Kelley RF, Randolph TW. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci 1998;87:1554-1559.
19. Kreilgaard L, Jones LS, Randolph TW, Frokjaer S, Flink JM, Manning MC, Carpenter JF. Effect of Tween 20 on freeze-thawing- and agitation induced aggregation of recombinant human factor XIII. J Pharm Sci 1998;87:1597-1603.